Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conjunctival Flora After Intravitreal Injections in Diabetics
NCT02337972Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of povidone-iodine in diabetic retinopathy (DR) and diabetic macular edema (DME), sponsored by Sheba Medical Center. Primary endpoint: Change of conjunctival flora and bacterial resistance at 4 months. Status: unknown.
02
Drugs
povidone-iodine
03
Conditions
diabetic retinopathy (DR)diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02337972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02337972.